Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Efficacy and Neuroimaging Mechanisms of Amygdala Temporal Interference Stimulation Therapy for Depression

NCT06461260 is registered in ClinicalTrials.gov with Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University as lead sponsor.

NCT NCT06461260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06461260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Efficacy and Neuroimaging Mechanisms of Amygdala Temporal Interference Stimulation Therapy for Depression
Lead sponsor
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
Phase
Not applicable
Overall status
Unknown status
Start date
May 27, 2024
Completion date
April 28, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder